<DOC>
	<DOCNO>NCT01570660</DOCNO>
	<brief_summary>Thiazoledinediones decrease blood glucose insulin-sensitizing property . Here investigator examine whether pioglitazone ( PIO ) improve insulin sensitivity independently glycemic control whether adipokines non-esterfied fatty acid ( NEFA ) serve mediator .</brief_summary>
	<brief_title>Phielix et al . : Hepatic Fat Content Adipokines</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>well control patient type 2 diabetes ( Hb1Ac &lt; 8 % ) insulin therapy comorbidities stable medication use last 6 month stable body weight last 6 month diet last 6 month Hb1Ac &gt; 8 % insulin therapy diabetesrelated comorbidities , like cardiovascular disease , neuropathology unstable medication use unstable body weight last 6 month ( &gt; 5 kg ) follow diet last 6 month</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>